SureTrader Nadex Advertisement PGUS
Home > Boards > US OTC > Medical - Equipment >

Arrayit Corporation (ARYC)

Add ARYC Price Alert      Hide Sticky   Hide Intro
Moderator: lucky,mydog, phinehas, bz777, Swiffer
Search This Board: 
Last Post: 3/29/2017 5:33:03 PM - Followers: 368 - Board type: Free - Posts Today: 46



Arrayit (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.


- Powerful Science for Life™



Corporate Overview

Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.

Corporate Philosophy
Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries.
Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene' Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series
NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and the Silicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company's products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.


OvaDx® Ovarian Cancer Diagnostic Test

In Development

Arrayit Diagnostics, Inc. provides the market's first large panel biomarker screening test for ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Arrayit Diagnostics will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.


Diagnostics - Parkinson's Disease

Parkinsons Disease
Arrayit has leveraged the company's patented and proprietary microarray discovery platform to decipher the molecular basis of Parkinson's Disease (PD). This important research project, completed as a collaboration with The Parkinson's Institute (Sunnyvale, California), offers exciting promise for the pre-symptomatic and post-symptomatic diagnosis and treatment of this serious neurodegenerative condition. Arrayit is currently seeking a strategic partner to accelerate FDA approval of the Arrayit PDx™ Parkinson's Disagnostic Test, speed the benchmarking of PDx™ as a companion diagnostic, and determine and enhance the efficacy of pipeline therapeutic proteins and small molecules.


Avant Diagnostics, Inc.

Definitive diagnostic screening test for early stage detection


About Avant Diagnostics, Inc.


Avant Diagnostics, Inc., ("AD") previously named Arrayit Diagnostics, Inc., is a Nevada corporation presently a majority-owned subsidiary of Arrayit Corporation ("Arrayit"). AD's business is based upon the completion of the human genome sequencing project. Genetic research is increasingly focused on identifying the variations of the specific genes in the genome. These variations are what define individual characteristics, including disease states or a statistical propensity for disease. The implications are far-reaching and impact not only the research community, but also the individual patients and the medical providers. Diagnostic tests that detect diseases very early in their progression will provide options for earlier treatments that may improve the patient's quality of life and prognosis by delaying or preventing disease progression or even death. Medical providers will incur major cost savings by avoiding costly late stage disease treatments.


© 2013 by Avant Diagnostics, Inc., all rights reserved.

Related Articles

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ARYC News: Current Report Filing (8-k) 12/05/2016 04:31:06 PM
ARYC News: Current Report Filing (8-k) 12/05/2016 03:16:26 PM
#41182  Sticky Note SKULL AND CROSSBONES FOR ARYC. lucky,mydog 02/09/17 08:24:37 AM
#41045  Sticky Note Here are the details and DD updates stockzoom 02/08/17 10:32:34 AM
#34865  Sticky Note All new shareholders, investors, and investment firms please Jimmy Jackson jr 11/23/16 10:23:48 AM
#42834   Oh he is right, the audit is completed. techmover 03/29/17 06:52:32 PM
#42833   How would you know unless you have insider information? mdimport 03/29/17 06:49:37 PM
#42832   no luck for me today!! :(... loaded what ANRK 03/29/17 05:33:03 PM
#42831   The audit is completed Jimmy Jackson jr 03/29/17 04:35:37 PM
#42830   Yes, you can pretty much tell what the techmover 03/29/17 04:10:05 PM
#42829   Unless you happen to be the seller, you mdimport 03/29/17 04:03:31 PM
#42828   lol!!!.. i have loaded on this one.. ..trying ANRK 03/29/17 03:49:08 PM
#42827   I'll pass...thx for the offer :) Jimmy Jackson jr 03/29/17 03:47:07 PM
#42826   .0046 it is me.. if someone is ready ANRK 03/29/17 03:45:58 PM
#42825   Welcome back PP1 :) Jimmy Jackson jr 03/29/17 03:33:08 PM
#42824   Yessir...and welcome aboard:) Jimmy Jackson jr 03/29/17 03:32:47 PM
#42823   People sell because of being impatient most of techmover 03/29/17 03:28:39 PM
#42822   the AVG Volume doubled..the chart is set for ANRK 03/29/17 03:26:10 PM
#42821   Hi back in, something is brewing here :)) PowerPlay1 03/29/17 02:53:12 PM
#42820   Looking better and better. techmover 03/29/17 02:15:10 PM
#42819   33 now millions213 03/29/17 02:05:52 PM
#42818   I think he's going to have to raise techmover 03/29/17 01:35:14 PM
#42817   I think you may have to raise it Jimmy Jackson jr 03/29/17 01:26:40 PM
#42816   if you are wondering about .0043 i here ANRK 03/29/17 12:34:04 PM
#42815   NEW...Arrayit reports microarray technology sale to top life Swiffer 03/29/17 12:20:19 PM
#42814   NEW...Arrayit reports microarray technology sale to top molecular Swiffer 03/29/17 12:20:15 PM
#42813   NEW...Arrayit reports microarray technology inquiry from top engineer Swiffer 03/29/17 12:20:00 PM
#42812   NEW...Arrayit reports $6,000 microarray technology RFQ from life Swiffer 03/29/17 12:19:56 PM
#42811   NEW...Arrayit reports $40,300 microarray services sale to leading Swiffer 03/29/17 12:19:52 PM
#42810   NEW...Arrayit 261K twitter followers compare favorably with $85.8B Swiffer 03/29/17 12:19:43 PM
#42809   ARYC may breakout soon, keep finger crossed! Ken1998 03/29/17 12:03:05 PM
#42808   31 now millions213 03/29/17 11:27:41 AM
#42807   33 now millions213 03/29/17 11:17:01 AM
#42804   If that's the case, SEC should suspend 99% techmover 03/29/17 10:56:24 AM
#42803   Nothing but PUMP and DUMP trap, algorithms are stockzoom 03/29/17 10:52:02 AM
#42802   I agree, I just don't get it why phinehas 03/29/17 10:50:52 AM
#42801   Okay Jimmy Jackson jr 03/29/17 10:46:46 AM
#42800  Restored You have no proof of what anyone selling mdimport 03/29/17 10:46:31 AM
#42799   Whoever has been selling knows NOTHING about Arrayit Jimmy Jackson jr 03/29/17 10:44:33 AM
#42798   Look how thin .005's are Jimmy Jackson jr 03/29/17 10:43:17 AM
#42797   .004's won't last long Jimmy Jackson jr 03/29/17 10:42:46 AM
#42796   Not me Jimmy Jackson jr 03/29/17 10:42:22 AM
#42795   Well with no news and people selling, it techmover 03/29/17 10:41:57 AM
#42794   That was opportunity that I missed. Absolutely nothing Jimmy Jackson jr 03/29/17 10:40:39 AM
#42793   Don't know but it was a nervous time techmover 03/29/17 10:39:28 AM
#42792   Who sold yesterday? lol Jimmy Jackson jr 03/29/17 10:36:15 AM
#42791   OK, something is truly taking place with this techmover 03/29/17 10:27:35 AM
#42790   A lot of positive trading today I wonder phinehas 03/29/17 10:27:18 AM
#42789   If you, or a friend of yours, visited mdimport 03/29/17 05:36:02 AM
#42786   Could be a computer algorithm. mfdesigner 03/28/17 07:44:51 PM
#42785   Arrayit new March 27 2017 company newsletter showcases Jimmy Jackson jr 03/28/17 07:43:53 PM
#42784   We may hear something good from the company Ken1998 03/28/17 06:25:29 PM
#42782   ARYC...BASED.ON.TRADING.LATE.TODAY...".SOMEBODY.KNOWS.SOMETHING.".!!.GLTA tm1119 03/28/17 05:56:18 PM
#42781   Yea really, because $25K isn't easy to come techmover 03/28/17 05:52:08 PM
#42780   Wow. Then it cost $25,000 to prop it Jimmy Jackson jr 03/28/17 05:47:40 PM